Nitorum Capital, L.P. Mannkind Corp Transaction History
Nitorum Capital, L.P.
- $549 Million
- Q2 2025
A detailed history of Nitorum Capital, L.P. transactions in Mannkind Corp stock. As of the latest transaction made, Nitorum Capital, L.P. holds 7,011,515 shares of MNKD stock, worth $37.7 Million. This represents 4.77% of its overall portfolio holdings.
Number of Shares
7,011,515
Previous 7,785,702
9.94%
Holding current value
$37.7 Million
Previous $39.2 Million
33.04%
% of portfolio
4.77%
Previous 7.16%
Shares
8 transactions
Others Institutions Holding MNKD
# of Institutions
249Shares Held
161MCall Options Held
1.24MPut Options Held
183K-
Black Rock Inc. New York, NY22.6MShares$121 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$97.7 Million0.0% of portfolio
-
State Street Corp Boston, MA10.7MShares$57.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA7.62MShares$41 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.85MShares$31.5 Million0.4% of portfolio
About MANNKIND CORP
- Ticker MNKD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 257,338,000
- Market Cap $1.38B
- Description
- MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...